HIGHLIGHTS
- who: Yaping Wu et al. from the KBRwyle, United States Medical University, China have published the paper: Primary squamous cell carcinoma of the breast: A case report and review of the literature, in the Journal: (JOURNAL) of May/25,/2015
- how: The results showed that atezolizumab combined with albumin paclitaxel could further prolong the PFS and OS of triple-negative breast cancer and the benefit was more obvious in the PD-L1 positive subgroup and the adverse reactions of immunity and chemotherapy could be tolerated. Dogu0306 ukan et_al used immunohistochemistry to detect the expression of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.